The University of Chicago Header Logo

Connection

Christine Bestvina to B7-H1 Antigen

Back to Details
This is a "connection" page, showing publications Christine Bestvina has written about B7-H1 Antigen.
Christine Bestvina
Connection Strength
0.043
B7-H1 Antigen
  1. Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. Clin Lung Cancer. 2022 07; 23(5):e317-e320.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.